Wang et al. wanted to further analyze the involvement of this pathway in the onset of preeclampsia by comparing the expression of TIM-3 on different immune cells in the decidua of preeclamptic and healthy pregnancies and analyzing whether there is a change in TIM-3 expression in the peripheral blood of preeclamptic patients. This evidence concerns the gene HAVCR2 and preeclampsia.